Edgewell Personal Care stock
EPCNYSEEdgewell Personal Care Company, Consumer DefensiveISIN US28035Q1022
56Score 56 out of 100, Neutral
Price and trend
89 / 100
Price history
+57% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 20% above it.
Since April 2026 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 52).
The price is 1.7% below its 52-week high. Largest decline in 20 years: 85% (May 2015 to December 2025).
Chart figures for advanced users
- SMA 50$27.84
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$24.30
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)52
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$15.91
- The lowest closing price of the last twelve months.
- Resistance$29.66
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Edgewell Personal Care Company belongs to the Household & Personal Products industry (United States) and, with a market value of $1.34B, is number 34 of 39 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $2.22B (down 1.3% year on year) and earnings of $25.4M (down 74.2%).
- For fiscal 2026, analysts expect on average revenue of $1.99B (down 10.4%) and adjusted earnings per share of $1.93 (down 24.2%).
Show more
- MEQIRI Score 56 out of 100 (Neutral): rank 203 of 295 in Consumer Defensive, median 62.
- Our model puts fair value at $29.95, with the price 3% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Share buybacksShare count down 13% since 2020.Capital allocation 53
Weaknesses
- Interest barely coveredOperating profit covers interest only 1.3 times.Stability 51
- Loss-makingLoss of $93.2M over the last 12 months.Fundamentals 65
- Margin fallingOperating margin 4.3%, average of the prior years 9% (to 2024).Profitability 37
Its standout strengths are technical analysis and momentum, while profitability and growth hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
The fundamentals are in the middle range.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among smaller stocks.
From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- high price swings
- price up very strongly over the past year
What lowers it
- price near its 52-week high
Valuation
Valuation signal
Fairly valuedIn our model the price counts as cheap below $21.39 and expensive above $49.92 (uncertainty high, based on the price swings of the past year).
Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $25.21, at 7.8% it would be $37.04.
Valuation metrics
From the cash-flow model alone; without earnings there is no industry value.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Jun 2026, revenue fell 7% on the twelve months before. Revenue has stayed largely stable since 2006.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 42%, operating 4%, net 1%.
Debt & balance sheet
latest quarterDebt is moderate, but interest coverage is weak. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 8 Feb 2027in 88 days
- Last reported
- 12 Nov 2026EPS reported $0.78 (expected $0.77)in line with expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $1.98−1.2%
- Revenue
- $2.02B−0.1%
- Earnings per share
- $2.11+0.3%
- Revenue
- $2.04B−0.1%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook confirmed
Share price after the results: −1.4%Ranges narrowed, gross margin outlook modestly reduced but still expanding; adjusted EBITDA, EPS and free cash flow largely in line with prior expectations.
“While the operating environment remains dynamic, we continue to expect stronger fourth quarter performance, gross margin expansion and adjusted EBITDA and adjusted EPS and free cash flow that remain largely in line with prior expectations.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 5 Aug 2026 (fiscal Q3 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases or sales in the last 6 months.
- Dunham John MSale
20 Nov 2025, Chief Accounting Officer
- Shares
- 333
- Price
- $17.21
- Value
- $5,731
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Edgewell Personal Care
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
295 rated companies in Consumer Defensive
- This company
- 56
- Sector median
- 62
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Household & Personal Products
The next larger and next smaller companies by market value
- Société BICBB.PA $2.93B67
- Newell BrandsNWL $2.5B46
- Spectrum Brands HoldingsSPB $2.03B64
- IntercosICOS.MI $1.45B64
- Oddity TechODD $1.13B56
- Helen of TroyHELE $888.61M52
- Gr. SarantisSAR.AT $829.28M67
- HonestHNST $556.33M51
ETFs that hold Edgewell Personal Care
Held by 11 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Avantis Global Small Cap Value UCITS ETFAVWS | 0.09% | 0.39% | €1.47B |
| State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETFZPRV | 0.08% | 0.30% | €944.34M |
| iShares S&P SmallCap 600 UCITS ETFIUS3 | 0.08% | 0.30% | €2.28B |
Show 5 more
| iShares MSCI World Small Cap CTB Enhanced ESG UCITS ETFCBUG | 0.06% | 0.35% | €434.1M |
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)ZPRR | 0.05% | 0.30% | €4.22B |
| Xtrackers Russell 2000 UCITS ETF 1CXRS2 | 0.05% | 0.30% | €2.17B |
| iShares MSCI World Small Cap UCITS ETFIUSN | 0.01% | 0.35% | €8.19B |
| iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETFSXRG | 0.00% | 0.43% | €2.48B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 11 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 30 Sep 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 23 Oct 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.